The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

KNSA FINANCIAL STATEMENTS

Kiniksa Pharmaceuticals Ltd — balance sheet, income statement and cash flow trends

KNSAKiniksa Pharmaceuticals Ltd

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue840.8 M $Gross Profit458.1 M $ · 54%Operating Income100.3 M $ · 12%Pre-tax Income114.3 M $ · 14%Net Income to Owners80.7 M $ · 10%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue840.8 M $+58.9%
Gross Profit458.1 M $+63.0%
Operating Income100.3 M $+2,140.2%
EBITDA112.1 M $+611.1%
Net Income to Owners80.7 M $+1,583.9%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets896.1 M
  • Equity654.1 M $73%
  • Current Liabilities171.2 M $19%
  • Long-term Liabilities70.7 M $8%

Key Figures

YoY change
Total Assets896.1 M $+35.5%
Total Liabilities242 M $+45.6%
Total Equity654.1 M $+32.1%
Cash & ST Investments525.9 M $+70.9%
Total Debt8.9 M $-8.9%
Net Debt-166.8 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0100 M200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M185.2 M $Operating-239.1 M $Investing31.7 M $Financing-22.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow185.2 M $+176.7%
Capital Expenditures2.1 M $+365.6%
Free Cash Flow183.1 M $+175.4%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on KNSA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.